Elizabeth Mallon

2.9k total citations
32 papers, 2.0k citations indexed

About

Elizabeth Mallon is a scholar working on Cancer Research, Oncology and Genetics. According to data from OpenAlex, Elizabeth Mallon has authored 32 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Cancer Research, 15 papers in Oncology and 9 papers in Genetics. Recurrent topics in Elizabeth Mallon's work include Breast Cancer Treatment Studies (21 papers), HER2/EGFR in Cancer Research (12 papers) and Estrogen and related hormone effects (8 papers). Elizabeth Mallon is often cited by papers focused on Breast Cancer Treatment Studies (21 papers), HER2/EGFR in Cancer Research (12 papers) and Estrogen and related hormone effects (8 papers). Elizabeth Mallon collaborates with scholars based in United Kingdom, United States and Switzerland. Elizabeth Mallon's co-authors include Joanne Edwards, Mitch Dowsett, Barry A. Gusterson, Jack Cuzick, John M.S. Bartlett, Tim Cooke, Clare Orange, Zahra Mohammed, Fahd Al‐Mulla and Karin Oien and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and The Lancet Oncology.

In The Last Decade

Elizabeth Mallon

31 papers receiving 2.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Elizabeth Mallon United Kingdom	19	1.1k	1.0k	708	443	355	32	2.0k
Véronique Becette France	18	983 0.9×	1.0k 1.0×	889 1.3×	313 0.7×	281 0.8×	56	2.2k
K. Anderson United States	12	1.6k 1.5×	1.4k 1.4×	1.2k 1.6×	386 0.9×	270 0.8×	20	2.7k
Anne‐Vibeke Lænkholm Denmark	30	1.2k 1.1×	1.2k 1.2×	1.2k 1.6×	276 0.6×	496 1.4×	120	2.6k
F. Spyratos France	23	796 0.7×	1.0k 1.0×	906 1.3×	290 0.7×	389 1.1×	52	2.0k
Barbro Linderholm Sweden	25	1.0k 1.0×	1.3k 1.2×	1.2k 1.8×	235 0.5×	334 0.9×	74	2.3k
Forrest D. Hsu Canada	8	1.4k 1.3×	1.7k 1.6×	1.1k 1.5×	598 1.3×	309 0.9×	8	3.0k
Claire E. Paish United Kingdom	18	1.4k 1.3×	1.7k 1.6×	1.4k 2.0×	528 1.2×	401 1.1×	21	3.0k
Lynda Sawyer United States	13	1.5k 1.4×	1.5k 1.5×	697 1.0×	552 1.2×	206 0.6×	18	2.5k
Rabiul Islam United States	7	1.3k 1.2×	1.3k 1.3×	649 0.9×	322 0.7×	155 0.4×	8	2.1k
Florence Lerebours France	29	1.2k 1.1×	1.4k 1.4×	915 1.3×	304 0.7×	248 0.7×	97	2.6k

Countries citing papers authored by Elizabeth Mallon

Since Specialization

Citations

This map shows the geographic impact of Elizabeth Mallon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elizabeth Mallon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elizabeth Mallon more than expected).

Fields of papers citing papers by Elizabeth Mallon

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elizabeth Mallon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elizabeth Mallon. The network helps show where Elizabeth Mallon may publish in the future.

Co-authorship network of co-authors of Elizabeth Mallon

This figure shows the co-authorship network connecting the top 25 collaborators of Elizabeth Mallon. A scholar is included among the top collaborators of Elizabeth Mallon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elizabeth Mallon. Elizabeth Mallon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Quinn, Jean A., Guang‐Yu Lian, László Romics, et al.. (2024). Elucidation of Dysregulated Pathways Associated With Hypoxia in Oestrogen Receptor‐Negative Breast Cancer. Cancer Medicine. 13(23). e70274–e70274. 1 indexed citations

Ammar, Aula, et al.. (2024). Spatial transcriptomic analysis of tumour with high and low CAIX expression in TNBC tissue samples using GeoMx™ RNA assay.. PubMed. 39(2). 177–200. 3 indexed citations

Bliss, Judith M., Holly Tovey, Abigail Evans, et al.. (2023). Clinico-pathologic relationships with Ki67 and its change with short-term aromatase inhibitor treatment in primary ER + breast cancer: further results from the POETIC trial (CRUK/07/015). Breast Cancer Research. 25(1). 39–39. 6 indexed citations

Pennel, Kathryn A.F., Elizabeth Mallon, Ditte K. Andersen, et al.. (2023). High expression of STAT3 within the tumour‐associated stroma predicts poor outcome in breast cancer patients. Cancer Medicine. 12(12). 13225–13240. 17 indexed citations

Mallon, Elizabeth, et al.. (2022). Multi-centre review of the management of patients undergoing surgery for phyllodes tumours. European Journal of Surgical Oncology. 48(5). e238–e238.

Smith, Ian, J.F.R. Robertson, Lucy Kilburn, et al.. (2020). Long-term outcome and prognostic value of Ki67 after perioperative endocrine therapy in postmenopausal women with hormone-sensitive early breast cancer (POETIC): an open-label, multicentre, parallel-group, randomised, phase 3 trial. The Lancet Oncology. 21(11). 1443–1454. 147 indexed citations

Gao, Qiong, Maggie C.U. Cheang, James P. Morden, et al.. (2019). Impact of aromatase inhibitor treatment on global gene expression and its association with antiproliferative response in ER+ breast cancer in postmenopausal patients. Breast Cancer Research. 22(1). 2–2. 16 indexed citations

Šestak, Ivana, Richard Buus, Jack Cuzick, et al.. (2018). Comparison of the Performance of 6 Prognostic Signatures for Estrogen Receptor–Positive Breast Cancer. JAMA Oncology. 4(4). 545–545. 204 indexed citations

Gao, Qiong, Elena López‐Knowles, Maggie C.U. Cheang, et al.. (2018). Major Impact of Sampling Methodology on Gene Expression in Estrogen Receptor–Positive Breast Cancer. JNCI Cancer Spectrum. 2(2). pky005–pky005. 7 indexed citations

10.

Stallard, Sheila, Eva Weiler-Mithoff, James Mansell, et al.. (2016). Six-year follow-up of patients treated with oncoplastic reduction mammoplasty: A cohort study. International Journal of Surgery. 26. 38–42. 17 indexed citations

11.

Tesson, Mathias, et al.. (2016). The combined endocrine receptor in breast cancer, a novel approach to traditional hormone receptor interpretation and a better discriminator of outcome than ER and PR alone. British Journal of Cancer. 115(8). 967–973. 22 indexed citations

12.

Ferrari, Nicola, Zahra Mohammed, Colin Nixon, et al.. (2014). Expression of RUNX1 Correlates with Poor Patient Prognosis in Triple Negative Breast Cancer. PLoS ONE. 9(6). e100759–e100759. 70 indexed citations

13.

McGlynn, Liane M., Samer Zino, Alasdair I. MacDonald, et al.. (2013). SIRT2: Tumour suppressor or tumour promoter in operable breast cancer?. European Journal of Cancer. 50(2). 290–301. 81 indexed citations

14.

Mohammed, Zahra, James J. Going, Donald C. McMillan, et al.. (2012). Comparison of visual and automated assessment of HER2 status and their impact on outcome in primary operable invasive ductal breast cancer. Histopathology. 61(4). 675–684. 25 indexed citations

15.

Edwards, Joanne, Beatrix Elsberger, Clare Orange, et al.. (2012). Identification of novel functional and spatial associations between sphingosine kinase 1, sphingosine 1‐phosphate receptors and other signaling proteins that affect prognostic outcome in estrogen receptor‐positive breast cancer. International Journal of Cancer. 132(3). 605–616. 39 indexed citations

16.

Dowsett, Mitch, Janine Salter, Lila Zabaglo, et al.. (2011). Predictive algorithms for adjuvant therapy: TransATAC. Steroids. 76(8). 777–780. 26 indexed citations

17.

Long, Jaclyn S., Clare Orange, Elizabeth Mallon, et al.. (2010). High Expression of Sphingosine 1-Phosphate Receptors, S1P1 and S1P3, Sphingosine Kinase 1, and Extracellular Signal-Regulated Kinase-1/2 Is Associated with Development of Tamoxifen Resistance in Estrogen Receptor-Positive Breast Cancer Patients. American Journal Of Pathology. 177(5). 2205–2215. 145 indexed citations

18.

Varga, Zsuzsanna & Elizabeth Mallon. (2009). Histology and Immunophenotype of Invasive Lobular Breast Cancer. Daily Practice and Pitfalls. Breast Disease. 30(1). 15–19. 13 indexed citations

19.

Pestalozzi, Bernhard C., David Zahrieh, Elizabeth Mallon, et al.. (2008). Distinct Clinical and Prognostic Features of Infiltrating Lobular Carcinoma of the Breast: Combined Results of 15 International Breast Cancer Study Group Clinical Trials. Journal of Clinical Oncology. 26(18). 3006–3014. 328 indexed citations

20.

Mallon, Elizabeth, et al.. (2000). The Basic Pathology of Human Breast Cancer. Journal of Mammary Gland Biology and Neoplasia. 5(2). 139–163. 42 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact